During 2018 Q4 the big money sentiment decreased to 0.94. That’s change of 0.69, from 2018Q3’s 1.63. 29 investors sold all, 80 reduced holdings as Acadia Healthcare Company, Inc. ratio is negative. 64 rose positions while 38 funds bought positions. Funds hold 99.01 million shares thus 3.22% less from 2018Q3’s 102.30 million shares.
Wells Fargo Mn reported 70,411 shs. Cubist Systematic Strategies Ltd Liability Company holds 7,433 shs or 0.01% of its capital. Panagora Asset has invested 0% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Ameriprise Financial, a Minnesota-based fund reported 675,856 shs. Moreover, Metropolitan Life Insurance New York has 0.01% invested in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) for 25,223 shs. Alliancebernstein L P owns 143,523 shs or 0% of their US capital. Aristotle Cap Boston Ltd Liability Corporation owns 501,097 shs or 1.06% of their US capital. Guggenheim Capital Ltd Liability Co owns 37,577 shs. United Services Automobile Association reported 0.01% stake. Shine Inv Advisory Serv accumulated 152 shs. Dupont Cap Management Corp has invested 0.01% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Quantbot Technology Limited Partnership has 9,496 shs. Systematic Financial Mgmt L P reported 0.03% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). 2,211 were reported by Qs Limited. Fisher Asset Mgmt Limited Co holds 0.01% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) or 165,716 shs.

Acadia Healthcare Company, Inc. registered $1.88 million net activity with 0 insider buys and 1 sale since November 1, 2018.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s earnings release is expected by WallStreet on May, 7, RTT reports. This year’s EPS analyst estimate is expected to be $0.35. That is 32.69 % down compareed to $0.52 EPS for last year. In case of $0.35 EPS ACHC’s profit could be $30.95M. -25.53 % negative EPS growth is what Wall Street’s forecasts after $0.47 reported EPS previous quarter. Ticker’s shares touched $28.38 during the last trading session after 2.10% change.Acadia Healthcare Company, Inc. is downtrending after having declined 20.29% since April 18, 2018. ACHC has 1.27M volume or 16.54% up from normal. The stock underperformed the S&P500 by 24.66%.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Ratings Coverage

Total analysts of 8 have positions in Acadia Healthcare Co (NASDAQ:ACHC) as follows: 4 rated it a “Buy”, 0 with “Sell” and 4 with “Hold”. The positive are 50%. Since November 14, 2018 according to StockzIntelligence Inc Acadia Healthcare Co has 13 analyst reports. On Monday, March 4 RBC Capital Markets maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) rating. RBC Capital Markets has “Buy” rating and $42 target. On Friday, March 1 the firm has “Hold” rating given by Robert W. Baird. On Monday, March 4 the rating was maintained by Raymond James with “Buy”. On Monday, March 4 the firm has “Hold” rating given by Credit Suisse. On Monday, March 4 the firm earned “Buy” rating by Citigroup. On Monday, March 4 the firm has “Neutral” rating given by Robert W. Baird. The company rating was maintained by BMO Capital Markets on Tuesday, March 5. On Monday, March 11 the company was maintained by Stephens. On Wednesday, November 14 Citigroup maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) with “Buy” rating.

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.The firm is worth $2.51 billion. The company's acute inpatient psychiatric facilities offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities include residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.Currently it has negative earnings. It also provides outpatient community services, such as community programs that are designed to provide therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder.

For more Acadia Healthcare Company, Inc. (NASDAQ:ACHC) news published recently go to: Globenewswire.com, Nasdaq.com, Seekingalpha.com, Benzinga.com or Nasdaq.com. The titles are as follows: “Acadia Healthcare Announces Date for Third Quarter 2018 Earnings Release – GlobeNewswire” published on October 24, 2018, “Acadia Healthcare (ACHC) Q4 Earnings Miss, Revenues Meet – Nasdaq” on March 01, 2019, “RBC questions Acadia selloff – Seeking Alpha” with a publish date: November 14, 2018, “RayJay: New Acadia Healthcare (NASDAQ:ACHC) CEO Gets Warm Welcome On The Street – Benzinga” and the last “Implied Volatility Surging for Acadia Healthcare (ACHC) Stock Options – Nasdaq” with publication date: December 17, 2018.